Filters close
Newswise: 1920_leo-mascarenhas-md-ms-cedars-sinai.jpg?10000
Released: 29-Apr-2024 7:05 PM EDT
Cedars-Sinai Guerin Children’s Expert Reelected to Leadership Position of Pediatric Oncology Organization
Cedars-Sinai

Cedars-Sinai Guerin Children’s pediatric oncologist Leo Mascarenhas, MD, MS, has been reelected as Children’s Oncology Group (COG) voting body chair for a second five-year term.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Apr-2024 5:00 PM EDT Released to reporters: 23-Apr-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Apr-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Vineyard Cares Business of the Year Presented to Huntsman Cancer Institute
Released: 29-Apr-2024 4:05 PM EDT
Vineyard Cares Business of the Year Presented to Huntsman Cancer Institute
Huntsman Cancer Institute at the University of Utah

The Vineyard Cares Business of the Year Award celebrates Huntsman Cancer Institute’s plan to establish a comprehensive cancer center in Vineyard, which will bring crucial cancer research and care closer to more communities in the region.

Newswise: Firefighter, a cancer survivor, discovers and embraces Sylvester’s large community of research and support
Released: 29-Apr-2024 4:05 PM EDT
Firefighter, a cancer survivor, discovers and embraces Sylvester’s large community of research and support
Sylvester Comprehensive Cancer Center

Naples (FL) firefighter, David Perez, initially kept his cancer diagnosis quiet, but now speaks out about the importance of fire fighter health and cancer in the fire service. “My eyes really opened up as to how many firefighters have been diagnosed with cancer and how many people there [Sylvester’s Firefighter Cancer Initiative] are fighting for us,” Perez said.

access_time Embargo lifts in 2 days
Embargo will expire: 1-May-2024 11:00 AM EDT Released to reporters: 29-Apr-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-May-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Cancer screening rates are significantly lower in US Federally Qualified Health Centers
Released: 29-Apr-2024 11:05 AM EDT
Cancer screening rates are significantly lower in US Federally Qualified Health Centers
University of New Mexico Comprehensive Cancer Center

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the US, relative to overall screening rates in the country.

Newswise: Cancer screening rates are significantly lower in U.S. Federally Qualified Health Centers
26-Apr-2024 4:00 PM EDT
Cancer screening rates are significantly lower in U.S. Federally Qualified Health Centers
University of Texas MD Anderson Cancer Center

A national study led by researchers at The University of Texas MD Anderson Cancer Center and The University of New Mexico (UNM) Comprehensive Cancer Center found major gaps in breast, cervical and colorectal cancer screening use in Federally Qualified Health Centers (FQHCs) in the U.S., relative to overall screening rates in the country.

26-Apr-2024 9:05 AM EDT
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
Lombardi Comprehensive Cancer Center at Georgetown University

A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center.

Newswise: Cancer cell–immune cell interactions predict immunotherapy response
Released: 29-Apr-2024 10:05 AM EDT
Cancer cell–immune cell interactions predict immunotherapy response
UT Southwestern Medical Center

By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.

Newswise: MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center
26-Apr-2024 11:00 AM EDT
MD Anderson and RUSH Unveil RUSH MD Anderson Cancer Center
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and RUSH University System for Health today announced a partnership to create RUSH MD Anderson Cancer Center.

Newswise: Rutgers Cancer Institute of New Jersey Researcher Elected to the American Academy of Arts and Sciences
Released: 26-Apr-2024 9:05 AM EDT
Rutgers Cancer Institute of New Jersey Researcher Elected to the American Academy of Arts and Sciences
Rutgers Cancer Institute of New Jersey

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, have announced that Eileen White, PhD, Deputy Director and Chief Scientific Officer at Rutgers Cancer Institute, has been elected as a member of the American Academy of Arts and Sciences.

Released: 25-Apr-2024 3:05 PM EDT
Statement on Passage of Diagnostic and Supplemental Imaging Legislation in Vermont
Susan G. Komen

Legislation signed by Gov. Phil Scott eliminates out-of-pocket expenses for diagnostic and supplemental imaging, which is crucial in ruling out breast cancer and a standard form of imaging for people at high-risk of breast cancer and survivors.

Newswise: Targeting specific protein regions offers a new treatment approach in medulloblastoma
Released: 25-Apr-2024 2:05 PM EDT
Targeting specific protein regions offers a new treatment approach in medulloblastoma
St. Jude Children's Research Hospital

Explore how research targeting EP300/CBP protein in Group 3 medulloblastoma may advance targeted pediatric brain tumor treatments by inhibiting bromodomains.

Newswise: UCLA Health urologists will showcase groundbreaking research at the 2024 American Urological Association Annual Meeting
Released: 25-Apr-2024 1:05 PM EDT
UCLA Health urologists will showcase groundbreaking research at the 2024 American Urological Association Annual Meeting
University of California, Los Angeles (UCLA), Health Sciences

Faculty, scientists, and urologists from UCLA Health Urology will present research data on the latest discoveries and innovations in urology at the 2024 American Urological Association’s (AUA) Annual Meeting in San Antonio, Texas, May 3-6.

Newswise: Cancer Survivors Reporting Loneliness Experience Higher Mortality Risk, New Study Shows
23-Apr-2024 12:00 PM EDT
Cancer Survivors Reporting Loneliness Experience Higher Mortality Risk, New Study Shows
American Cancer Society (ACS)

A new study led by researchers at the American Cancer Society (ACS) showed people surviving cancer who reported feeling more lonely experienced a higher mortality risk compared to survivors reporting low or no loneliness.

Newswise: Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy
Released: 25-Apr-2024 10:05 AM EDT
Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital's Transplant and Cell Therapy
Rutgers Cancer Institute of New Jersey

The Foundation for the Accreditation of Cellular Therapy (FACT) has once again awarded Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital’s (RWJUH) Transplant and Cell Therapy Program accreditation under the FACT-JACIE International Standards for Hematopoietic Cellular Therapy

Newswise: Blocking gene may halt growth of breast cancer cells
Released: 25-Apr-2024 10:05 AM EDT
Blocking gene may halt growth of breast cancer cells
UT Southwestern Medical Center

Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center researchers showed in a new study.

Newswise: Living with Stage 3 lung cancer in your 80s and 90s
Released: 25-Apr-2024 9:05 AM EDT
Living with Stage 3 lung cancer in your 80s and 90s
University of Chicago Medical Center

Mickey Allen was 89 years old when she was diagnosed with Stage 3B lung cancer. How did her age impact her treatment options? University of Chicago Medicine oncologists explain what factors they consider when creating treatment plans for patients in their 80s and 90s.

Released: 24-Apr-2024 12:00 PM EDT
MD Anderson Research Highlights for April 24, 2024
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   

Showing results

120 of 24700

close
5.2359